Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer

BACKGROUND: Although 1% has been used as cut-off for estrogen receptor (ER) positivity, several studies have reported that tumors with ER < 1% have characteristics similar to those with 1% ≤ ER < 10%. We hypothesized that in patients with human epidermal growth factor 2 (HER2)-negative breast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Oncol
Main Authors: Fujii, T., Kogawa, T., Dong, W., Sahin, A. A., Moulder, S., Litton, J. K., Tripathy, D., Iwamoto, T., Hunt, K. K., Pusztai, L., Lim, B., Shen, Y., Ueno, N. T.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834134/
https://ncbi.nlm.nih.gov/pubmed/28961844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx397
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados